Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Advances in qPCR
Conferences  \  Advances in qPCR  \  Agenda  \  Peter Mouritzen
RegisterLogin

Peter Mouritzen's Biography


Peter Mouritzen, Vice President, Exiqon A/S

Peter Mouritzen, MSc, PhD,  is Director of Product development at Exiqon Life Sciences.  Exiqon Life Sciences develop molecular biology tools for LNA™ based detection of nucleic acids and functional analysis. In particular the miRCURY brand is a set of tools that support the entire workflow in miRNA research from sample preparation, over miRNA profiling with arrays and qPCR, including validation by qPCR and in situ hybridization, to functional analysis with LNA™ miRNA inhibitors.

Peter Mouritzen Image

Development of a LNA based miRNA RT-qPCR System and a Custom qPCR Tool for Design of miRNA and ncRNA Assays

Wednesday, 27 April 2011 at 10:00

Add to Calendar ▼2011-04-27 10:00:002011-04-27 11:00:00Europe/LondonDevelopment of a LNA based miRNA RT-qPCR System and a Custom qPCR Tool for Design of miRNA and ncRNA AssaysAdvances in qPCR in BostonBostonSELECTBIOenquiries@selectbiosciences.com

Locked Nucleic Acid (LNA) qPCR has enabled sensitive and pre-amplification-free miRNA expression profiling in plasma samples from colorectal cancer patients and healthy controls. Strategies will be discussed for data normalization, quality control, and revealing of unwanted dataset bias.

Add to Calendar ▼2011-04-26 00:00:002011-04-27 00:00:00Europe/LondonAdvances in qPCRAdvances in qPCR in BostonBostonSELECTBIOenquiries@selectbiosciences.com


Conference Sponsors
Other Conferences
Nanomedicine & LNPs Asia 2026
Location: Shenzhen, China
Date: 21/11/2026 - 22/11/2026


Organoids & Organs-on-Chips Asia 2026
Location: Shenzhen, China
Date: 21/11/2026 - 22/11/2026